But the expression of PLK4 was decreased in some hematologic malignancies compared to normal tissues, such as in 82.0% of lymphomas, 80.5% of myelodysplastic syndromes (MDS) and 60% of acute lymphoblastic leukemia (ALL) and did not display oncogene roles. Here, PLK4 is linked to myelodysplastic syndrome.